Dialysis centers and infusion suites carry a site selection burden unlike almost any other healthcare real estate category — the clinical, operational, and regulatory demands of these uses stack on top of commercial lease economics in ways that can make or break a facility before the first patient walks through the door.
Why Healthcare Site Selection for Dialysis and Infusion Is Different
Dialysis and infusion providers operate under a set of physical and regulatory constraints that most commercial tenants never face. Water quality, electrical capacity, ADA compliance for medically vulnerable patients, and proximity to referral networks all converge on a single address. Getting that address wrong is expensive to fix and nearly impossible to fix quickly.
The capital investment in a dialysis or infusion facility is front-loaded and largely non-recoverable. Dialysis centers require specialized plumbing for water treatment systems, reinforced electrical panels, and medical gas rough-ins that cost hundreds of thousands of dollars in tenant improvement dollars. Those dollars are spent before the first revenue cycle begins, so the site decision carries an outsized financial consequence.
Infusion suites add their own layer of complexity. Many infusion therapies are administered to immunocompromised patients who cannot travel long distances, so the trade area analysis must be tighter and more patient-centric than a typical retail or medical office search. The overlap between dialysis and infusion site requirements is significant, but each modality introduces its own non-negotiable checklist items that advisers must work through methodically.
The structured framework of 7 Questions Dialysis and Infusion Providers Should Ask About a Site exists precisely because these requirements don't emerge from a single discipline — they draw from facilities planning, clinical operations, real estate economics, and regulatory compliance simultaneously.
Question 1: Does the Building's Electrical Infrastructure Support the Load?
Dialysis equipment draws continuous, significant electrical loads. A single dialysis station typically requires a dedicated circuit, and a center with twelve to twenty stations will aggregate those demands rapidly. Before any letter of intent is drafted, an adviser must obtain the building's electrical specifications — panel size, available amperage, and transformer capacity — and have them reviewed by an MEP engineer against the operator's equipment schedule.
The question is not simply whether power is available but whether it is available in the right form and in the right location. Dialysis centers often need power delivered to multiple zones across the clinical floor, not just to a single electrical room. If the existing infrastructure requires a new transformer or a substation upgrade, those costs must be assigned clearly in the lease negotiation before the tenant commits.
Infusion suites have a lighter electrical burden than dialysis centers, but they still require reliable, clean power for infusion pumps, monitoring equipment, and refrigeration units for temperature-sensitive biologics. A building that experiences frequent voltage fluctuations or has aging switchgear is a clinical risk, not just a facilities inconvenience. Advisers representing infusion operators should request the building's utility history and any available power quality reports.
Backup power deserves equal scrutiny. Dialysis patients cannot safely interrupt a treatment mid-session, and many infusion therapies have similar continuity requirements. Whether the building has an emergency generator, its capacity, and its switchover time are non-negotiable items to verify before the site moves forward.
Question 2: Can the Space Support the Water Treatment Requirements?
Water is the central utilities question for dialysis. A hemodialysis center consumes hundreds of gallons of purified water per treatment per patient, and that water must meet ultrapure standards. The water treatment system — typically a reverse osmosis system — requires both a cold water supply line of adequate pressure and flow rate and a drain with sufficient capacity to handle the reject water stream.
The building's domestic water pressure and the diameter of the supply lines feeding the potential space must be verified against the operator's water system specifications. A building that cannot deliver the required pressure and flow without major utility upgrades will impose a cost burden that can easily exceed the leasing economics. These numbers must be in hand before the tenant improvement budget is finalized.
Floor drain capacity and the ability to route reject water to the building drain system require equally careful review. In older buildings, the drain infrastructure may not support the continuous discharge volumes a dialysis water system produces. A plumbing engineer's report is not optional in this site evaluation — it is a prerequisite to a credible financial model.
Infusion suites need clean water for compounding preparation areas if sterile compounding is performed on-site, though many infusion operators use outsourced pharmacy partners and have a lighter water requirement. Even so, hand-hygiene sink placement and plumbing stub-out locations within the suite layout affect clinical workflow and must be mapped against the floor plan at the site evaluation stage.
Question 3: What Are the Structural and Floor-Load Specifications?
Water treatment equipment is heavy. A reverse osmosis skid, storage tanks, and distribution loops for a mid-sized dialysis center can aggregate to several thousand pounds of concentrated load. The building's structural engineer should review the equipment placement plan against the slab or floor system specifications before the tenant commits.
Multi-story buildings introduce additional complexity. If the dialysis space is above grade, the mechanical equipment may need to be located in a ground-floor utility room with distribution runs up to the clinical floor, adding plumbing and construction cost. If the space is on a ground-floor slab, verifying slab thickness and subgrade conditions is still necessary, particularly in markets with expansive soils or high water tables.
Infusion suites are generally less demanding from a structural standpoint, but the recliner chairs used for infusion therapy — when fully occupied — represent a distributed live load that should be confirmed against the building's design live load. Converted office or retail spaces that were not originally designed for healthcare occupancy require this confirmation before a letter of intent is signed.
The structural review is also the right moment to assess the building's floor-to-floor height and the available plenum space. HVAC systems for healthcare uses often require larger duct sizes than standard commercial systems, and insufficient plenum depth forces expensive coordination between mechanical and structural elements.
Question 4: Does the HVAC System Meet Healthcare Ventilation Standards?
Dialysis centers and infusion suites are classified as healthcare occupancies under most building codes, which triggers ventilation requirements that are more stringent than standard commercial standards. Air change rates, humidity controls, pressure relationships between clinical and support zones, and filtration specifications all differ materially from a typical office or retail fit-out.
The building's existing HVAC system capacity — tonnage, air volume, and duct distribution — must be evaluated against the clinical operator's design criteria. In many suburban medical office buildings, the base building HVAC is designed for general office occupancy at two to three tons per thousand square feet. Healthcare uses often require more, and the incremental cost of upgrading the system falls to the tenant unless it is negotiated into the landlord's work letter.
Exhaust requirements add another dimension. Dialysis treatment areas require dedicated exhaust to prevent odor migration into adjacent spaces, and biomedical waste storage areas have their own exhaust and pressure requirements. An adviser who treats the HVAC question as a standard commercial checklist item will miss cost exposures that surface only during construction documentation.
The commissioning of HVAC systems in healthcare spaces is also a regulatory requirement in many jurisdictions. The lease should address who is responsible for commissioning costs and documentation, and whether the landlord will provide as-built mechanical drawings to support that process.
Question 5: Is the Location Accessible to the Patient Population It Will Serve?
Patient accessibility for dialysis and infusion is a clinical and financial variable, not merely a convenience. Dialysis patients typically receive treatment three times per week, every week, for the rest of their lives. A center that is difficult to reach by public transit, paratransit, or private vehicle will experience higher no-show rates, which creates clinical risk and revenue leakage simultaneously.
The trade area analysis for a dialysis center should map the prevalence of end-stage renal disease in the surrounding population against drive time and transit access, not just radius distance. Medicare data on ESRD prevalence is publicly available at the county and regional level, and an adviser who does not layer that data into the site evaluation is working with an incomplete picture.
Infusion patients, many of whom are receiving treatment for chronic conditions such as multiple sclerosis, Crohn's disease, or rheumatoid arthritis, face similar access constraints. Many are immunocompromised and cannot use crowded public transit reliably. The site's proximity to parking — both volume and ADA accessibility — is a clinical operations issue, not just a tenant amenity preference.
Referral network proximity matters equally. Dialysis centers that are co-located near nephrology practices, or infusion suites that maintain a short drive time to the oncology or rheumatology offices that generate referrals, will outperform geographically isolated sites with otherwise similar physical attributes. The site selection process must map the referring physician network before the shortlist is finalized.
Question 6: What Does the Lease Structure Do to the Financial Model?
Healthcare real estate leases are long. Dialysis centers typically require ten to fifteen year initial terms to justify the capital investment in clinical infrastructure. Infusion suites may accept shorter terms, but even those rarely sign leases under five years. The duration, rent escalation mechanics, renewal option structure, and capital responsibility provisions all feed directly into the financial model that determines whether the site is viable.
Effective rent — the total contractual rent obligation expressed as a per-square-foot average over the full lease term — is the first metric an adviser should build. A below-market starting rent with aggressive escalations can produce an effective rent that exceeds a flat market rate by a meaningful margin over a fifteen-year term. Lease net present value analysis, discounting the rent obligation at the operator's cost of capital, is the correct tool for comparing options that have different escalation structures.
Tenant improvement allowance negotiation is critical in this category. Healthcare TI costs are substantially higher than standard commercial TI costs — plumbing, electrical, medical gas, infection control construction, and specialized finishes all add cost. An allowance of thirty to forty dollars per square foot that might be acceptable for a standard medical office fit-out may be a fraction of what a dialysis center requires. The gap between the allowance and the actual TI cost is a capital obligation that must be carried by the operator, and its NPV must be reflected in the site comparison model.
Restoration obligations deserve careful attention. Leases for dialysis centers often require the tenant to restore the space to its original condition at lease expiration, which could mean removing specialized plumbing, electrical, and mechanical systems. The cost of restoration at the end of a fifteen-year lease, discounted back to present value, is a real economic liability that belongs in the financial model.
Question 7: What Regulatory and Zoning Approvals Does the Site Require?
Healthcare uses are frequently subject to zoning requirements that differ from standard commercial or medical office uses. Dialysis centers and infusion suites may require a conditional use permit, a certificate of need in states that still have CON programs, or a specific healthcare district zoning classification. The approval timeline and uncertainty associated with these requirements are real project risks that must be priced into the site evaluation.
Certificate of Need requirements, where they exist, can add months to the regulatory pathway and introduce competitive risk — another operator may apply for a CON in the same service area and trigger a contested case proceeding. An adviser who does not verify the CON landscape before recommending a site is leaving a material project risk unexamined. CON programs vary significantly by state and by modality, and the governing statutes in each jurisdiction must be verified with the operator's regulatory counsel.
Local building codes may require a change of occupancy permit when converting a commercial space to a healthcare occupancy. The change-of-occupancy review can surface requirements for additional egress, accessibility upgrades, fire suppression improvements, and seismic upgrades in applicable zones — all of which add time and cost to the project schedule. These requirements are not predictable from the lease abstract alone; they require a code analysis of the specific building.
Health department licensure is a parallel pathway that must be managed alongside the building permit process. Dialysis centers are licensed at the state level in most jurisdictions, with CMS certification layered on top. Infusion suites may be licensed as ambulatory surgery centers, outpatient clinics, or under a pharmacy license depending on the services offered. The sequence and timing of these approvals must be mapped against the lease commencement date and the rent obligation to avoid paying rent before the facility is licensed to operate.
Building a Scoring Matrix for Site Evaluation
A structured scoring matrix is the practical tool that translates the seven questions above into a comparable format across multiple candidate sites. The matrix assigns a weight to each criterion — electrical capacity, water infrastructure, structural adequacy, HVAC compliance, patient access, lease economics, and regulatory pathway — and scores each site against that criterion. The weighted average score produces a defensible ranking that the operator's leadership can review and challenge.
Weighting decisions reflect the operator's clinical priorities and capital constraints. For a dialysis operator with a constrained TI budget, lease economics and landlord TI commitment may carry a heavier weight. For an infusion operator entering a new market, referral network proximity and regulatory timeline may dominate. The matrix is a tool for making those priorities explicit and consistent across the evaluation team.
The scoring process should capture not just the current state of each criterion but the cost and time required to bring a deficient site up to standard. A site with inadequate electrical infrastructure is not automatically disqualified — it may still rank favorably if the landlord will fund the upgrade and the schedule impact is manageable. The matrix must accommodate that nuance rather than treating each criterion as a binary pass-fail gate.
Assembling the Right Evaluation Team
No single professional can answer all seven questions without support. The site evaluation team for a dialysis or infusion facility should include a commercial real estate adviser with healthcare experience, an MEP engineer capable of reviewing electrical and mechanical infrastructure against clinical specifications, a structural engineer, a code consultant, and regulatory counsel familiar with the state's healthcare licensing framework.
Integrating Patient Access Data Into the Site Analysis
Patient access analysis for dialysis and infusion sites goes beyond mapping the location on a drive-time polygon. The analysis should incorporate the demographic composition of the trade area, the prevalence of the target condition in that population, the current supply of competing facilities, and the anticipated referral volume from nearby physicians.
Medicare's publicly available ESRD data, state health department facility registries, and CMS provider enrollment data are all legitimate inputs to the access analysis. These sources vary in their update frequency and geographic granularity, and an adviser should understand their limitations before drawing conclusions. Presenting an access analysis to an operator's leadership team without disclosing the data vintage and coverage gaps is a credibility risk.
Paratransit access deserves specific attention for dialysis patients. Many end-stage renal disease patients rely on non-emergency medical transportation, and the routing patterns and service reliability of NEMT providers in a given market affect whether a site is clinically reachable for the population it is designed to serve. An adviser who treats this as a soft factor rather than a scored criterion is underweighting a real clinical operations variable.
Connecting Site Evaluation to Portfolio Strategy
Healthcare operators who run multiple dialysis or infusion sites face a portfolio management challenge that extends beyond the individual site evaluation. Lease expirations, renewal windows, capital reinvestment cycles, and regulatory re-licensure dates all accumulate across the portfolio and require coordinated attention. Missing a renewal option exercise deadline on a high-performing site is a recoverable but expensive mistake.
The portfolio view also reveals market concentration risk. An operator who has three dialysis centers within a tightly defined geography is exposed to a single regulatory action — a CMS survey finding, a state enforcement proceeding, or a zoning change — in ways that a geographically distributed portfolio is not. The site selection process for new locations should be informed by the existing portfolio map, not evaluated in isolation.
Turning Site Evaluation Into a Repeatable Process
The seven questions framework is most valuable when it is embedded in a repeatable evaluation process rather than applied ad hoc to each site. A clinical operator entering a new market for the first time and a regional dialysis network opening its fifteenth center should both be working from a documented evaluation protocol that captures the criteria, the data sources, the specialist roles, and the financial model structure.
A repeatable process produces comparable data across sites and across time. When the operator's real estate committee reviews three candidate sites simultaneously, the comparison is credible only if each site was evaluated against the same criteria in the same way. A structured scoring matrix, built on verified site data rather than broker opinions, is the foundation of that credibility.
The site selection process for dialysis and infusion facilities is demanding precisely because it requires rigorous answers to questions that span multiple disciplines. Advisers who bring a systematic framework — one that integrates clinical requirements, physical infrastructure, lease economics, and regulatory risk — deliver a qualitatively different level of service than those who treat healthcare real estate as standard commercial practice with a few extra checklist items.
About Advantai
Advantai is a commercial real estate intelligence and operations platform operated by ADVANTAGE AI LLC, a Delaware limited liability company. It connects client relationships, property research, documents and financial decisions in one workspace for commercial real estate teams — advisers and brokerage teams, occupier and facility teams, and portfolio teams. The platform covers CRM and origination, requirements and site selection, Property X-Ray (an interactive 3D building workspace), financial modeling and comparison, document intelligence, transactions and diligence, client collaboration, and portfolio strategy with critical dates. The optional Super Agent upgrade adds specialist, source-backed research and automated scenario analysis.
Get Started with Advantai
Ready to see your next move clearly? Go to advantaico.com, click Request a demo and tell us about your next project. Prefer to start with a single project? Visit advantaico.com/getting-started to plan your first one.